Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma

25 Aug 2022

Abstract excerpt

Background As the crosstalk between metabolism and antitumor immunity continues to be unraveled, we aim to develop a prognostic gene signature that integrates lipid metabolism and immune features for patients with lung adenocarcinoma (LUAD). Methods First, differentially expressed genes (DEGs) related to lipid metabolism in LUAD were detected, and subgroups of LUAD patients were identified via the unsupervised...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36091041
DOI: 10.3389/fimmu.2022.950001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinomaPMID 36091041Read ↗

Comprehensive analyses of metabolism-related lncRNA for LUADSemantic proximity Read ↗

A risk score model based on lipid metabolism-related genes could predict response to immunotherapy and prognosis of lung adenocarcinoma: a multi-dataset study and cytological validationSemantic proximity Read ↗

Individualized Lipid Metabolism-Associated Six-Gene Signature for Prediction of Overall Survival, Immune Infiltration, Immunotherapy Response, and Potential Candidate Drugs in Lung Squamous Cell Carcinoma Patients: Development and ValidationSemantic proximity Read ↗

Lipid metabolism gene-wide profile and survival signature of lung adenocarcinomaSemantic proximity Read ↗

Lipid metabolism gene-wide profile and survival signature of lung adenocarcinomaSemantic proximity Read ↗

Detection of the Fatty Acid Metabolism‐Linked Genes in Lung Adenocarcinoma as Biomarkers for Clinical Prognosis and Immunotherapeutic TargetsSemantic proximity Read ↗

Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.Semantic proximity Read ↗

Novel Lipid Metabolism-Related Gene Signature Associated with Clinical and Immune Features in Lung Adenocarcinoma Patients Experiencing Lymph Node MetastasisSemantic proximity Read ↗

Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune responseSemantic proximity Read ↗

Novel Lipid Metabolism-Related Gene Signature in Lung Adenocarcinoma Patients Experiencing Lymph Node MetastasisSemantic proximity Read ↗

Development of a Tumour Metabolism and Immune Microenvironment-Based Prognostic Model for Prognosis and Anti-Cancer Drug Response in Lung AdenocarcinomaSemantic proximity Read ↗

A Novel Fatty Acid Metabolism Signature Predicts Prognoses, Tumor Immune Microenvironment, and Immunotherapy Response In Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.